デフォルト表紙
市場調査レポート
商品コード
1566779

抗菌プラスチック市場:添加剤別、プラスチック別、最終用途別:世界の機会分析と産業予測、2024~2033年

Antimicrobial Plastics Market By Additive , By Plastic By End-Use : Global Opportunity Analysis and Industry Forecast, 2024-2033


出版日
ページ情報
英文 250 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
抗菌プラスチック市場:添加剤別、プラスチック別、最終用途別:世界の機会分析と産業予測、2024~2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 250 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗菌プラスチック市場の2023年の市場規模は431億米ドルで、2033年には874億米ドルに達し、2024~2033年のCAGRは7.4%で成長すると予測されています。

抗菌プラスチックは、微生物の増殖を抑制するように設計された添加剤やコーティング剤を注入した人工材料です。これらのプラスチックに使用される一般的な抗菌剤には、銀イオン、銅、亜鉛、トリクロサンや第4級アンモニウム化合物などの有機化合物が含まれます。これらの薬剤は微生物の細胞機能を破壊し、破壊や増殖抑制につながります。抗菌プラスチックの主要利点は、感染リスクの低減、製品の保存期間の延長、清潔さの維持などです。抗菌プラスチックは、表面や製品中の微生物汚染を最小限に抑え、安全性と衛生を向上させる。

特にCOVID-19の大流行を受けて、衛生と安全に対する消費者の意識が高まり、抗菌製品に対する需要が高まっており、これが世界の抗菌プラスチック市場の成長を促進する主要要因となっています。加えて、病院関連感染の憂慮すべき有病率の増加により、医療施設は感染率を低下させるために医療機器、設備、表面に抗菌プラスチックを採用することを余儀なくされています。Journal of Hospital Infectionに掲載された2018年の研究では、病院環境における抗菌性表面の使用により、病院関連感染の発生率を最大30%削減できることが実証されました。米国だけでも年間約170万人の患者が病院関連感染に苦しんでいることを考えると、この削減効果は大きいです。さらに、病院、クリニック、医療機器製造を含む世界の医療産業の拡大が、市場成長に大きく寄与しています。さらに、食品業界は賞味期限の延長と食品の安全性の確保に注力しており、これが包装材料への抗菌プラスチックの採用につながっています。Food Control in 2020に掲載された研究では、抗菌包装は生鮮食品の賞味期限を25~50%延ばすことができると述べています。この研究では、銀ナノ粒子を含む抗菌フィルムが細菌の増殖を抑制し、食品の品質をより長く保つことが強調されました。しかし、抗菌剤をプラスチックに組み込むことに関連する高コストが市場の成長を抑制しています。また、銀ナノ粒子やトリクロサンなどの特定の抗菌剤の使用は、その潜在的な毒性により環境に対する懸念を引き起こし、市場成長の妨げとなっています。これとは反対に、環境に優しくサステイナブル抗菌ソリューションの開拓は、環境への懸念に対処し、環境意識の高い消費者や産業を惹きつけており、市場の成長に有利な機会を提供すると期待されています。さらに、抗菌剤とプラスチック製造技術の革新により、抗菌プラスチックの効能と多様性が向上し、様々な産業にとってより魅力的なものとなっています。

世界の抗菌プラスチック市場は、添加剤、プラスチック、最終用途、地域に区分されます。添加剤別では、市場は無機と有機に分類されます。プラスチックベースでは、エンジニアリング、高機能、その他に分別されます。最終用途別では、医療、包装、自動車、消費財、建築・建設、その他に細分化されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカなどの地域で調査されています。

主要調査結果

添加剤別では、有機セグメントが2033年までに急成長が見込まれます。

プラスチック別では、エンジニアリングプラスチックセグメントが予測期間を通じてリードすると予測されています。

最終用途別では、医療が今後数年間で主要セグメントとして浮上すると予測されます。

地域別では、抗菌プラスチックはアジア太平洋で高い注目を集めるとみられます。

本レポートで可能なカスタマイズ(追加費用とスケジュールがあります。)

  • 国別または地域別の追加分析-市場規模と予測
  • 過去の市場データ
  • 顧客/消費者/原料サプライヤー一覧-バリューチェーン分析
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 抗菌プラスチック市場:添加剤別

  • 市場概要
  • 無機
  • 有機

第5章 抗菌プラスチック市場:プラスチック別

  • 市場概要
  • エンジニアリング
  • 高性能
  • その他

第6章 抗菌プラスチック市場:用途別

  • 市場概要
  • 医療
  • 包装
  • 自動車
  • 消費財
  • 建築・建設
  • その他

第7章 抗菌プラスチック市場:地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の抗菌プラスチック市場
    • カナダの抗菌プラスチック市場
    • メキシコの抗菌プラスチック市場
  • 欧州
    • 主要市場動向と機会
    • フランスの抗菌プラスチック市場
    • ドイツの抗菌プラスチック市場
    • イタリアの抗菌プラスチック市場
    • スペインの抗菌プラスチック市場
    • 英国の抗菌プラスチック市場
    • その他の欧州の抗菌プラスチック市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の抗菌プラスチック市場
    • 日本の抗菌プラスチック市場
    • インドの抗菌プラスチック市場
    • 韓国の抗菌プラスチック市場
    • オーストラリアの抗菌プラスチック市場
    • その他のアジア太平洋の抗菌プラスチック市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの抗菌プラスチック市場
    • 南アフリカの抗菌プラスチック市場
    • サウジアラビアの抗菌プラスチック市場
    • その他のラテンアメリカ・中東・アフリカの抗菌プラスチック市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング(2023年)

第9章 企業プロファイル

  • INEOS Group
  • BioCote Limited
  • Lonza Group
  • Microban International
  • RTP Company, LLC
  • Avient Corporation
  • BASF SE
  • Palram Industries Ltd.
  • LyondellBasell Industries Holdings B.V.
  • DuPont De Nemours, Inc.
目次
Product Code: A05351

The antimicrobial plastics market was valued at $43.1 billion in 2023, and is projected to reach $87.4 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

Antimicrobial plastics are engineered materials infused with additives or coatings designed to inhibit the growth of microorganisms. Common antimicrobial agents used in these plastics include silver ions, copper, zinc, and organic compounds like triclosan and quaternary ammonium compounds. These agents disrupt microbial cell functions, leading to their destruction or inhibition of growth. The primary benefits of antimicrobial plastics include reducing the risk of infection, extending the shelf life of products, and maintaining cleanliness. They help in minimizing microbial contamination on surfaces and in products, thereby enhancing safety and hygiene.

Increase in consumer awareness about hygiene and safety, especially in the wake of the COVID-19 pandemic, has fostered the demand for antimicrobial products, which is a key factor driving the growth of the global global antimicrobial plastics market. In addition, alarming increase in prevalence of hospital-associated infections has enforced healthcare facilities to adopt antimicrobial plastics for medical devices, equipment, and surfaces to reduce infection rates. A 2018 study published in the Journal of Hospital Infection demonstrated that the use of antimicrobial surfaces in hospital settings could reduce the incidence of hospital-associated infections by up to 30%. This reduction is significant, given the fact that approximately 1.7 million patients suffer from hospital-associated infections annually in the U.S. alone. Furthermore, the expansion of the global healthcare industry, including hospitals, clinics, and medical device manufacturing, is significantly contributing toward the market growth. Moreover, the food industry is focusing on extending shelf life and ensuring food safety, which has led to the adoption of antimicrobial plastics in packaging materials. A study published in Food Control in 2020-an international journal that focuses on food safety and food quality concerns and preventative control measures that improve public health-states that antimicrobial packaging could extend the shelf life of fresh produce by 25-50%. The study highlighted that antimicrobial films containing silver nanoparticles inhibited bacterial growth, thus preserving food quality for a longer period. However, high cost associated with the incorporation of antimicrobial agents into plastics restrains the market growth. In addition, use of certain antimicrobial agents, such as silver nanoparticles and triclosan, has raised environmental concerns due to their potential toxicity, thus hampering the market growth. On the contrary, the development of eco-friendly and sustainable antimicrobial solutions addresses environmental concerns and attracts environmentally conscious consumers and industries, which is expected to offer lucrative opportunities for the market growth. Moreover, innovations in antimicrobial agents and plastic manufacturing techniques have improved the efficacy and variety of antimicrobial plastics, making them more attractive to various industries.

The global antimicrobial plastics market is segmented into additive, plastic, end use, and region. By additive, the market is classified into inorganic and organic. On the basis of plastic, it is segregated into engineering, high-performance, and others. Depending on end use, it is fragmented into healthcare, packaging, automotive, consumer goods, building & construction, and others. Region wise, it is studied across areas such as North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By additive, the organic segment is expected to witness rapid growth by 2033.

On the basis of plastic, the engineering plastics segment is anticipated to lead throughout the forecast period.

Depending on end use, healthcare is projected to emerge as a leading segment in the coming years.

Region wise, antimicrobial plastic is likely to gain high prominence in Asia-Pacific.

Competition Analysis

Competitive analysis and profiles of the major players in the global Antimicrobial Plastics Market include INEOS Group, BioCote Limited, Lonza Group, Microban International, RTP Company, LLC, Avient Corporation, BASF SE, Palram Industries Ltd., LyondellBasell Industries Holdings B.V., and DuPont de Nemours, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional country or region analysis- market size and forecast
  • Historic market data
  • List of customers/consumers/raw material suppliers- value chain analysis
  • SWOT Analysis

Key Market Segments

By Additive

  • Inorganic and
  • Organic

By Plastic

  • Engineering
  • High-Performance
  • Others

By End-Use

  • Healthcare
  • Packaging
  • Automotive
  • Consumer Goods
  • Building and Construction
  • And Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • INEOS Group
    • BioCote Limited
    • Lonza Group
    • Microban International
    • RTP Company, LLC
    • Avient Corporation
    • BASF SE
    • Palram Industries Ltd.
    • LyondellBasell Industries Holdings B.V.
    • DuPont de Nemours, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANTIMICROBIAL PLASTICS MARKET, BY ADDITIVE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Additive
  • 4.2. Inorganic And
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Organic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANTIMICROBIAL PLASTICS MARKET, BY PLASTIC

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Plastic
  • 5.2. Engineering
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. High-Performance
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANTIMICROBIAL PLASTICS MARKET, BY END-USE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End-use
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Packaging
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Automotive
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Consumer Goods
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Building And Construction
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. And Others
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country

CHAPTER 7: ANTIMICROBIAL PLASTICS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Additive
    • 7.2.3. Market Size and Forecast, By Plastic
    • 7.2.4. Market Size and Forecast, By End-use
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Antimicrobial Plastics Market
      • 7.2.6.1. Market Size and Forecast, By Additive
      • 7.2.6.2. Market Size and Forecast, By Plastic
      • 7.2.6.3. Market Size and Forecast, By End-use
    • 7.2.7. Canada Antimicrobial Plastics Market
      • 7.2.7.1. Market Size and Forecast, By Additive
      • 7.2.7.2. Market Size and Forecast, By Plastic
      • 7.2.7.3. Market Size and Forecast, By End-use
    • 7.2.8. Mexico Antimicrobial Plastics Market
      • 7.2.8.1. Market Size and Forecast, By Additive
      • 7.2.8.2. Market Size and Forecast, By Plastic
      • 7.2.8.3. Market Size and Forecast, By End-use
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Additive
    • 7.3.3. Market Size and Forecast, By Plastic
    • 7.3.4. Market Size and Forecast, By End-use
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Antimicrobial Plastics Market
      • 7.3.6.1. Market Size and Forecast, By Additive
      • 7.3.6.2. Market Size and Forecast, By Plastic
      • 7.3.6.3. Market Size and Forecast, By End-use
    • 7.3.7. Germany Antimicrobial Plastics Market
      • 7.3.7.1. Market Size and Forecast, By Additive
      • 7.3.7.2. Market Size and Forecast, By Plastic
      • 7.3.7.3. Market Size and Forecast, By End-use
    • 7.3.8. Italy Antimicrobial Plastics Market
      • 7.3.8.1. Market Size and Forecast, By Additive
      • 7.3.8.2. Market Size and Forecast, By Plastic
      • 7.3.8.3. Market Size and Forecast, By End-use
    • 7.3.9. Spain Antimicrobial Plastics Market
      • 7.3.9.1. Market Size and Forecast, By Additive
      • 7.3.9.2. Market Size and Forecast, By Plastic
      • 7.3.9.3. Market Size and Forecast, By End-use
    • 7.3.10. UK Antimicrobial Plastics Market
      • 7.3.10.1. Market Size and Forecast, By Additive
      • 7.3.10.2. Market Size and Forecast, By Plastic
      • 7.3.10.3. Market Size and Forecast, By End-use
    • 7.3.11. Rest of Europe Antimicrobial Plastics Market
      • 7.3.11.1. Market Size and Forecast, By Additive
      • 7.3.11.2. Market Size and Forecast, By Plastic
      • 7.3.11.3. Market Size and Forecast, By End-use
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Additive
    • 7.4.3. Market Size and Forecast, By Plastic
    • 7.4.4. Market Size and Forecast, By End-use
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Antimicrobial Plastics Market
      • 7.4.6.1. Market Size and Forecast, By Additive
      • 7.4.6.2. Market Size and Forecast, By Plastic
      • 7.4.6.3. Market Size and Forecast, By End-use
    • 7.4.7. Japan Antimicrobial Plastics Market
      • 7.4.7.1. Market Size and Forecast, By Additive
      • 7.4.7.2. Market Size and Forecast, By Plastic
      • 7.4.7.3. Market Size and Forecast, By End-use
    • 7.4.8. India Antimicrobial Plastics Market
      • 7.4.8.1. Market Size and Forecast, By Additive
      • 7.4.8.2. Market Size and Forecast, By Plastic
      • 7.4.8.3. Market Size and Forecast, By End-use
    • 7.4.9. South Korea Antimicrobial Plastics Market
      • 7.4.9.1. Market Size and Forecast, By Additive
      • 7.4.9.2. Market Size and Forecast, By Plastic
      • 7.4.9.3. Market Size and Forecast, By End-use
    • 7.4.10. Australia Antimicrobial Plastics Market
      • 7.4.10.1. Market Size and Forecast, By Additive
      • 7.4.10.2. Market Size and Forecast, By Plastic
      • 7.4.10.3. Market Size and Forecast, By End-use
    • 7.4.11. Rest of Asia-Pacific Antimicrobial Plastics Market
      • 7.4.11.1. Market Size and Forecast, By Additive
      • 7.4.11.2. Market Size and Forecast, By Plastic
      • 7.4.11.3. Market Size and Forecast, By End-use
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Additive
    • 7.5.3. Market Size and Forecast, By Plastic
    • 7.5.4. Market Size and Forecast, By End-use
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Antimicrobial Plastics Market
      • 7.5.6.1. Market Size and Forecast, By Additive
      • 7.5.6.2. Market Size and Forecast, By Plastic
      • 7.5.6.3. Market Size and Forecast, By End-use
    • 7.5.7. South Africa Antimicrobial Plastics Market
      • 7.5.7.1. Market Size and Forecast, By Additive
      • 7.5.7.2. Market Size and Forecast, By Plastic
      • 7.5.7.3. Market Size and Forecast, By End-use
    • 7.5.8. Saudi Arabia Antimicrobial Plastics Market
      • 7.5.8.1. Market Size and Forecast, By Additive
      • 7.5.8.2. Market Size and Forecast, By Plastic
      • 7.5.8.3. Market Size and Forecast, By End-use
    • 7.5.9. Rest of LAMEA Antimicrobial Plastics Market
      • 7.5.9.1. Market Size and Forecast, By Additive
      • 7.5.9.2. Market Size and Forecast, By Plastic
      • 7.5.9.3. Market Size and Forecast, By End-use

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. INEOS Group
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. BioCote Limited
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Lonza Group
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Microban International
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. RTP Company, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Avient Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BASF SE
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Palram Industries Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. LyondellBasell Industries Holdings B.V.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. DuPont De Nemours, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments